Biocon and Quark Pharmaceuticals Collaborate to Develop Novel siRNA based Therapeutics
Bangalore, India, and Fremont, CA, December 18, 2013 Biocon Ltd, Asia’s premier biotechnology company, and Quark Pharmaceuticals, Inc,. a world leader in the discovery and development of siRNA-based therapeutics, announced today that they have entered into a Licensing & Collaboration agreement for the development of a range of siRNA ( small interfering RNA) based novel therapeutics. This